PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Disease ReportsPancreatic neoplasms
MeSH D010190 - pancreatic neoplasms
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D010182:Pancreatic diseases
0 Companies
0 Drugs
Success rate
D004067:Digestive system neoplasms
0 Companies
0 Drugs
Success rate
D004701:Endocrine gland neoplasms
0 Companies
0 Drugs
Success rate
D010190: 
Pancreatic neoplasms
64 Companies
14 Drugs
$
Success rate
D000077779:Pancreatic intraductal neoplasms
0 Companies
0 Drugs
Success rate
D007516:Islet cell adenoma
0 Companies
0 Drugs
Success rate
D018273:Islet cell carcinoma
7 Companies
2 Drugs
$
Success rate
D021441:Pancreatic ductal carcinoma
21 Companies
1 Drug
$
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
Accord HealthcareDocetaxel Docetaxel  2011-06-08   
Docetaxel Docetaxel Accord  2012-05-22   
Fluorouracil Fluorouracil  2007-04-26   
Mitomycin Mitomycin  1998-04-30   
Sunitinib Sunitinib Accord  2021-02-11   
Irinotecan Irinotecan  2008-11-21   
Alembic PharmaceuticalsDocetaxel Docetaxel  2023-02-28   
Fluorouracil Fluorouracil  2023-03-03   
AllerganDocetaxel Docetaxel  2013-04-12   
Tamoxifen Tamoxifen  2003-02-20   
Irinotecan Irinotecan  2008-02-27   
Amneal PharmaceuticalsDocetaxel Docetaxel  2018-01-19   
Amryt PharmaOctreotide Mycapssa  2022-12-02   
ApotexDocetaxel Docetaxel  2012-01-11   
Tamoxifen Tamoxifen  2011-09-23   
APP PharmaceuticalsFluorouracil Fluorouracil  1986-03-21   
Astex PharmaceuticalsMitomycin Mitozytrex  2002-11-14   
AstraZenecaTamoxifen Nolvadex  1982-01-01   
Bausch Health CompaniesFluorouracil Carac  2000-10-27   
Fluorouracil Efudex  1982-01-01   
1
2
3
4
5
6
7
>
Clinical Trials
Historical Success Rate
Phase 1
70%
184/261
Phase 2
22%
62/282
Phase 3
34%
30/88
Approved: 11Overall Success rate: 5%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Allergan
Docetaxel,
Bevifimod
Astex Pharmaceuticals
Mitomycin,
Rubitecan,
Doxecitine
AstraZeneca
Tamoxifen,
Rintatolimod,
Docusate,
Fluorodopa f-18,
Camizestrant,
Cilmostim,
Gilvetmab,
Aglatimagene besadenovec,
Cediranib,
Galunisertib,
Saracatinib,
Vicriviroc,
Lornoxicam,
ADAVOSERTIB,
Ceralasertib,
Bevifimod,
DANVATIRSEN,
Doxecitine,
Nadide,
Naptumomab estafenatox,
Nepidermin,
Patidegib,
Polyglycolic acid,
Telbermin,
Insulin,
D-glutamate,
Fludeoxyglucose f-18,
Globulin, immune,
Bos taurus adrenal cortex corticosteroids,
Anthracycline,
Viaject,
Aminoglycoside,
Doxorubin,
PALACAPARIB,
Ec-17,
AZD-5153,
Folinoral,
Hydroxydaunomycin,
Cc5013,
Docetaxol,
Taxane,
Isoxaflutole
Bausch Health Companies
Fluorouracil,
Nepidermin
Baxter
Ifosfamide
Bristol Myers Squibb
Paclitaxel,
Mitomycin,
Losartan,
Gilvetmab,
Entinostat,
Spartalizumab,
Brivanib alaninate,
Lornoxicam,
SOTIGALIMAB,
Bevifimod,
CABIRALIZUMAB,
Doxecitine,
Polyglycolic acid,
Selicrelumab,
URELUMAB,
Globulin, immune,
Mk3475,
Mrtx1719,
Antineoplaston a10,
Hiltonol,
Folinoral,
Histone-arginine methyltransferase carm1,
Docetaxol,
Hidroxicloroquina,
Taxane,
Sominex
1
2
3
4
5
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use